Relief Therapeutics Holding AG Share Price Other OTC
Equities
RLFTF
CH0100191136
Biotechnology & Medical Research
Sales 2022 | 60.81L 67.82L 57Cr | Sales 2023 | 60.33L 67.29L 56Cr | Capitalization | 2.5Cr 2.78Cr 232.41Cr |
---|---|---|---|---|---|
Net income 2022 | -5Cr -5.58Cr -465.65Cr | Net income 2023 | -9.8Cr -11Cr -912.68Cr | EV / Sales 2022 | 19.3 x |
Net cash position 2022 | 1.49Cr 1.66Cr 138.7Cr | Net cash position 2023 | 1.03Cr 1.14Cr 95Cr | EV / Sales 2023 | 2.44 x |
P/E ratio 2022 |
-2.5
x | P/E ratio 2023 |
-0.24
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.87% |
Managers | Title | Age | Since |
---|---|---|---|
Ram Selvaraju
CHM | Chairman | 45 | 25/16/25 |
Michelle Lock
BRD | Director/Board Member | 55 | 28/22/28 |
Anthony M. Kim
PRN | Corporate Officer/Principal | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Selvaraju
CHM | Chairman | 45 | 25/16/25 |
Paolo Galfetti
PRN | Corporate Officer/Principal | 59 | 27/21/27 |
Michelle Lock
BRD | Director/Board Member | 55 | 28/22/28 |
1st Jan change | Capi. | |
---|---|---|
+49.41% | 5.79TCr | |
+41.65% | 4.03TCr | |
-6.72% | 3.99TCr | |
-5.96% | 2.85TCr | |
+12.99% | 2.64TCr | |
-19.82% | 1.93TCr | |
+32.35% | 1.24TCr | |
-0.08% | 1.22TCr | |
+25.18% | 1.22TCr |